Cargando…
Investigating the safety and activity of the use of BTT1023 (Timolumab), in the treatment of patients with primary sclerosing cholangitis (BUTEO): A single-arm, two-stage, open-label, multi-centre, phase II clinical trial protocol
INTRODUCTION: Primary sclerosing cholangitis (PSC) is a progressive inflammatory liver disease characterised by relentless liver fibrosis and a high unmet need for new therapies. Preventing fibrosis represents an important area of interest in the development of vital new drugs. Vascular adhesion pro...
Autores principales: | Arndtz, Katherine, Corrigan, Margaret, Rowe, Anna, Kirkham, Amanda, Barton, Darren, Fox, Richard P, Llewellyn, Laura, Athwal, Amrita, Wilkhu, Manpreet, Chen, Yung-Yi, Weston, Chris, Desai, Amisha, Adams, David H, Hirschfield, Gideon M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734279/ https://www.ncbi.nlm.nih.gov/pubmed/28674140 http://dx.doi.org/10.1136/bmjopen-2016-015081 |
Ejemplares similares
-
Rare but heard: using asynchronous virtual focus groups, interviews and roundtable discussions to create a personalised psychological intervention for primary sclerosing cholangitis: a protocol
por: Ranieri, Veronica, et al.
Publicado: (2019) -
Barriers to implementation of stratified care in primary biliary cholangitis: a scoping exercise
por: Corrigan, Margaret, et al.
Publicado: (2019) -
Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis
por: Chen, Yung-Yi, et al.
Publicado: (2019) -
Vascular adhesion protein-1 is elevated in primary sclerosing cholangitis, is predictive of clinical outcome and facilitates recruitment of gut-tropic lymphocytes to liver in a substrate-dependent manner
por: Trivedi, Palak J, et al.
Publicado: (2018) -
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis
por: de Vries, Elisabeth M, et al.
Publicado: (2018)